top of page
Search
Biologics R&D: select news
Cost-effectiveness of bivalent respiratory syncytial virus Prefusion F (RSVpreF) maternal vaccine among infants in the United States
https://pubmed.ncbi.nlm.nih.gov/40383082/
jeanfrancoismaison
May 191 min read
Integrin β3 N125 glycosylation is essential for human cytomegalovirus entry into fibroblasts
https://pubmed.ncbi.nlm.nih.gov/40383337/
jeanfrancoismaison
May 191 min read
A shared inflammatory signature across severe malaria syndromes manifested by transcriptomic, proteomic and metabolomic analyses
https://pubmed.ncbi.nlm.nih.gov/40383794/
jeanfrancoismaison
May 191 min read
mRNAdesigner: an integrated web server for optimizing mRNA design and protein translation in eukaryotes
https://pubmed.ncbi.nlm.nih.gov/40384581/
jeanfrancoismaison
May 191 min read
Targeting KRASG12C Mutation: Development of effective strategies to overcome drug resistance and limited efficacy
https://pubmed.ncbi.nlm.nih.gov/40381222/
jeanfrancoismaison
May 191 min read
Predicting kinase target inhibition level for efficacy in rheumatoid arthritis: A translational approach based on collagen-induced arthritis rodent studies
https://pubmed.ncbi.nlm.nih.gov/40382809/
jeanfrancoismaison
May 191 min read
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
https://pubmed.ncbi.nlm.nih.gov/40383129/
jeanfrancoismaison
May 191 min read
Nano-Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type-2 Diabetes Mellitus
https://pubmed.ncbi.nlm.nih.gov/40384055/
jeanfrancoismaison
May 191 min read
Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpox
https://pubmed.ncbi.nlm.nih.gov/40239465/
jeanfrancoismaison
May 181 min read
Advances in artificial intelligence-envisioned technologies for protein and nucleic acid research
https://pubmed.ncbi.nlm.nih.gov/40252991/
jeanfrancoismaison
May 181 min read
The role and implication of rotavirus VP8∗ in viral infection and vaccine development
https://pubmed.ncbi.nlm.nih.gov/40378555/
jeanfrancoismaison
May 181 min read
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials
https://pubmed.ncbi.nlm.nih.gov/40378861/
jeanfrancoismaison
May 181 min read
Parasite and host immune factors that impact the development of a mucosal vaccine for Cryptosporidium
https://pubmed.ncbi.nlm.nih.gov/40379259/
jeanfrancoismaison
May 181 min read
Engineering pyroptotic vesicles as personalized cancer vaccines
https://pubmed.ncbi.nlm.nih.gov/40379868/
jeanfrancoismaison
May 181 min read
Recent advances in therapeutic cancer vaccines
https://pubmed.ncbi.nlm.nih.gov/40379970/
jeanfrancoismaison
May 181 min read
Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers
https://pubmed.ncbi.nlm.nih.gov/40379270/
jeanfrancoismaison
May 181 min read
MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization
https://pubmed.ncbi.nlm.nih.gov/40379833/
jeanfrancoismaison
May 181 min read
Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development
https://pubmed.ncbi.nlm.nih.gov/40379874/
jeanfrancoismaison
May 181 min read
Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab
https://pubmed.ncbi.nlm.nih.gov/40379907/
jeanfrancoismaison
May 181 min read
In vivo CAR engineering for immunotherapy
https://pubmed.ncbi.nlm.nih.gov/40379910/
jeanfrancoismaison
May 181 min read
bottom of page